Literature DB >> 28615397

Recurrent vulvovaginal candidiasis.

Mathieos Belayneh1, Evan Sehn1, Christina Korownyk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28615397      PMCID： PMC5471085     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

Review 1.  Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

Authors:  Matthew E Falagas; Gregoria I Betsi; Stavros Athanasiou
Journal:  J Antimicrob Chemother       Date:  2006-06-21       Impact factor: 5.790

2.  Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.

Authors:  Debarti Ray; Ravinder Goswami; Uma Banerjee; Vatsla Dadhwal; Deepti Goswami; Piyali Mandal; Vishnubhatla Sreenivas; Narayana Kochupillai
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

Review 3.  Recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel
Journal:  Am J Obstet Gynecol       Date:  2015-07-09       Impact factor: 8.661

4.  Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.

Authors:  A C Roth; I Milsom; L Forssman; P Wåhlén
Journal:  Genitourin Med       Date:  1990-10

5.  Managing recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole.

Authors:  A Spinillo; L Colonna; G Piazzi; F Baltaro; A Monaco; A Ferrari
Journal:  J Reprod Med       Date:  1997-02       Impact factor: 0.142

6.  The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole.

Authors:  I W Fong
Journal:  Genitourin Med       Date:  1992-06

7.  Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel; Harold C Wiesenfeld; Mark Martens; Penny Danna; Thomas M Hooton; Anne Rompalo; Malcolm Sperling; Charles Livengood; Benson Horowitz; James Von Thron; Libby Edwards; Helene Panzer; Teng-Chiao Chu
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

8.  The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis.

Authors:  I W Fong
Journal:  Genitourin Med       Date:  1994-04

9.  Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.

Authors:  Eleni Pitsouni; Christos Iavazzo; Matthew E Falagas
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

10.  Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).

Authors:  Gilbert Donders; Gert Bellen; Geert Byttebier; Luc Verguts; Piet Hinoul; Ronald Walckiers; Michel Stalpaert; Annie Vereecken; Johan Van Eldere
Journal:  Am J Obstet Gynecol       Date:  2008-10-30       Impact factor: 8.661
View more
  1 in total

Review 1.  Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-28       Impact factor: 3.944
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.